Mangoceuticals, Inc. Common Stock (MGRX)vsTempus AI, Inc. Class A Common Stock (TEM)
MGRX
Mangoceuticals, Inc. Common Stock
$0.38
-2.09%
HEALTHCARE · Cap: $6.35M
TEM
Tempus AI, Inc. Class A Common Stock
$46.43
-11.16%
HEALTHCARE · Cap: $8.77B
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 328948% more annual revenue ($1.36B vs $414,580). MGRX leads profitability with a 0.0% profit margin vs -22.2%. TEM earns a higher WallStSmart Score of 31/100 (F).
MGRX
Avoid23
out of 100
Grade: F
TEM
Avoid31
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Revenue surging 36.1% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
0.0% earnings growth
Elevated debt levels
Trading at 20.0x book value
ROE of -72.7% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MGRX
The strongest argument for MGRX centers on Price/Book, Debt/Equity.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 36.1% demonstrates continued momentum.
Bear Case : MGRX
The primary concerns for MGRX are EPS Growth, Market Cap, Profit Margin.
Bear Case : TEM
The primary concerns for TEM are EPS Growth, Debt/Equity, Price/Book. Debt-to-equity of 1.96 is elevated, increasing financial risk.
Key Dynamics to Monitor
MGRX profiles as a value stock while TEM is a hypergrowth play — different risk/reward profiles.
TEM is growing revenue faster at 36.1% — sustainability is the question.
MGRX generates stronger free cash flow (-1M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TEM scores higher overall (31/100 vs 23/100) and 36.1% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Mangoceuticals, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
Visit Website →Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?